Fresenius Medical Care
Fresenius Medical Care AG & Co. KGaA
Kommanditgesellschaft auf Aktien with Aktiengesellschaft as partner with unlimited liability
Traded as FWBFME
NYSEFMS
Industry Health care
Founded 1996
Headquarters Bad Homburg, Germany
Key people
Rice Powell (CEO and Chairman of the executive board), Michael Brosnan (CFO), Roberto Fusté (Chief Executive Officer for Asia-Pacific), Dr. Emanuele Gatti (Chief Executive Officer for Europe, Middle East, Africa and Latin America), Ronald Kuerbitz (Chief Executive Officer for North America), Gerd Krick (Chairman of the supervisory board)
Products Kidney dialysis products and services, Therapuetic Aphoresis Products
Revenue US $14.6 billion (2013)[1]
US $2,256 million (2013)[1]
Profit US $1,110 million (2013)[1]
US $22.120 billion (end 2013)[1]
US $9.485 billion (end 2013)[1]
Number of employees
90,690 (FTE, end 2013)[1]
Website www.freseniusmedicalcare.com

Fresenius Medical Care is a German company specializing in the production of medical supplies, primarily to facilitate or aid renal dialysis. It is 30% owned by the health care company Fresenius.[2] As of December 31, 2015, the number of Fresenius Medical Care shares held by its largest shareholder, Fresenius SE & Co. KGaA remained unchanged at around 94.4 M. This corresponds to a 30.9% interest in its share capital.

Manufacturing

Fresenius Medical Care operates more than 40 production sites on all continents. Its largest plants in terms of production output are in the U.S. (Ogden, Utah, and Concord, California), Germany (Schweinfurt and St. Wendel), and Japan (Buzen). These plants are categorized as large and small with 25 large facilities and 15 small ones worldwide which cater to local demand for dialysis products.[3] Plants that fall under the concentrates division, manufacture finished products from raw materials, such as sodium chloride, dextrose, and magnesium, to name a few. Raw materials go through a complex mixing and packaging process.

Devices

Fresenius Medical Care manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices include Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices including the Crit-line device. The dialysis machines are manufactured in one of two plants to serve the globe. These plants are located in Schweinfurt, Germany and Concord, California. Crit-line devices are manufactured in Concord, California.

Distribution

Distribution is where the finished product, from Manufacturing, comes in on Semi-Trucks to be distributed to dialysis clinics, hospitals, and home dialysis patients. These products are then used in the dialysis process.

On 30 October 2006, the manufacturing facility (Fresenius Hemocare) in Redmond, Washington was shut down. Fresenius Hemocare has stopped going by the name Fresenius Hemocare and now goes by the name Fresenius-Kabi LLC. The closing of one of two entities inside of Hemocare allowed for the name change and takes Hemocare from the Medical Care group to the Kabi group.

In 2012, Fresenius acquired Liberty Dialysis Holdings, in a deal which entailed the sale of its outpatient dialysis clinics in 43 local markets within the U.S.

In 2013, Fresenius Medical Care NA acquired Shiel Medical Laboratory Inc, expanding services to New York City metro area.[]

Dialysis Units

Fresenius Medical Care Renal Services Limited runs 54 dialysis units across England[4] and more across Wales. In September 2014 new renal dialysis units run by Fresenius were opened at Withybush General Hospital and West Wales General Hospital, with a contract to run for at least 7 years.[5]

Acquisitions

In August 2017, Fresenius acquired NxStage Medical, a medical device manufacturer based in Lawrence, Massachusetts for a reported $2 billion dollars.[6]

References

  1. ^ a b c d e f "Fresenius Medical Care reports fourth quarter and full year 2013 results". Fresenius Medical Care. 26 December 2014. Retrieved 2013. 
  2. ^ Fresenius Medical Care. "Shareholder structure". Retrieved . 
  3. ^ KGaA, Fresenius Medical Care AG & Co. "Operations and Strategy < Annual Report 2012 - Fresenius Medical Care AG & Co. KGaA". reports.fmc-ag.com. 
  4. ^ "Provider: Fresenius Medical Care Renal Services Limited". Care Quality Commission. Retrieved 2014. 
  5. ^ "Date finally set for opening of Withybush Hospital's multi-million pound dialysis unit". Milford & West Wales Mercury. 8 September 2014. Retrieved 2014. 
  6. ^ Stendahl, Max (2017-08-07). "Why NxStage's CEO 'feels really good' about selling his medical device firm". Boston Business Journal. Retrieved . 

External links


  This article uses material from the Wikipedia page available here. It is released under the Creative Commons Attribution-Share-Alike License 3.0.


Fresenius_Medical_Care
 



 
Connect with defaultLogic
What We've Done
Led Digital Marketing Efforts of Top 500 e-Retailers.
Worked with Top Brands at Leading Agencies.
Successfully Managed Over $50 million in Digital Ad Spend.
Developed Strategies and Processes that Enabled Brands to Grow During an Economic Downturn.
Taught Advanced Internet Marketing Strategies at the graduate level.



Manage research, learning and skills at defaultLogic. Create an account using LinkedIn or facebook to manage and organize your IT knowledge. defaultLogic works like a shopping cart for information -- helping you to save, discuss and share.


  Contact Us